|
|
||||||||
OPEN ACCESS ARTICLE
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS: CONCISE REVIEW |
aDepartment of Obstetrics and Gynecology, Stony Brook University, Stony Brook, New York, USA;
bLaboratory of Molecular Vertebrate Embryology, The Rockefeller University, New York, New York, USA
Key Words. Endometrial bleeding associated factor • Lefty • Embryonic stem cells • Review
Correspondence: Siamak Tabibzadeh, M.D., P.O. Box 160, Albertson, New York 11507-0160, USA. Telephone: 516-484-2831; Fax: 516-801-1943; e-mail: tabibzadeh{at}bioscience.org
Received February 6, 2006;
accepted for publication May 16, 2006.
First published online in STEM CELLS EXPRESS May 25, 2006.
Stem cells are functionally defined by their ability to self-renew and generate a progeny capable of creation or reconstitution of various tissues. Microarray analysis has shown a member of the transforming growth factor (TGF)-ß superfamily, Lefty, to be the single most abundant inhibitor in stem cells and in maternal decidua that supports embryo implantation. Lefty is regulated by pathways such as Smad (Sma and Mad [mothers against decapentaplegic]) and WNT (wingless-type) and by the transcriptional factor Oct3/4 (octamer-binding transcription factor 3/4), which support "stemness." Lefty is also induced upon exit from the state of stemness, including forced in vitro differentiation, and leukemia inhibitory factor withdrawal. Lefty is a candidate in cell-fate decisions because of its unique ability to modulate the expression of TGF-ß family proteins such as Nodal and by blanket inhibition of the activity of members of this family which require EGF-CFC (epidermal growth factor-Cripto, Frl-1, and Cryptic) as a coreceptor.
This article has been cited by other articles:
![]() |
L.-M. Postovit, N. V. Margaryan, E. A. Seftor, D. A. Kirschmann, A. Lipavsky, W. W. Wheaton, D. E. Abbott, R. E. B. Seftor, and M. J. C. Hendrix Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells PNAS, March 18, 2008; 105(11): 4329 - 4334. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
